| 901 | 34077739 | Osimertinib-resistant NSCLC cells activate ERBB2 and YAP/TAZ and are killed by neratinib. | Biochem Pharmacol | 2021 Aug |
1 |
| 902 | 34089720 | Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma. | J Invest Dermatol | 2021 Dec |
2 |
| 903 | 34097573 | Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function. | Platelets | 2022 Apr 3 |
1 |
| 904 | 34099621 | The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML. | Blood Cancer J | 2021 Jun 7 |
2 |
| 905 | 34099760 | Human immune system adaptations to simulated microgravity revealed by single-cell mass cytometry. | Sci Rep | 2021 Jun 7 |
2 |
| 906 | 34117374 | Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation. | Cancer Gene Ther | 2021 Jun 11 |
1 |
| 907 | 34121564 | Novel CD123 polyaptamer hydrogel edited by Cas9/sgRNA for AML-targeted therapy. | Drug Deliv | 2021 Dec |
1 |
| 908 | 34188118 | Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer. | Sci Rep | 2021 Jun 29 |
9 |
| 909 | 34209829 | Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells. | Cells | 2021 Jun 29 |
2 |
| 910 | 34262659 | Combined inhibition of STAT and Notch signalling effectively suppresses tumourigenesis by inducing apoptosis and inhibiting proliferation, migration and invasion in glioblastoma cells. | Anim Cells Syst (Seoul) | 2021 |
1 |
| 911 | 34288360 | Whole-genome analysis of TET dioxygenase function in regulatory T cells. | EMBO Rep | 2021 Aug 4 |
2 |
| 912 | 34318593 | Anti-growth and pro-apoptotic effects of dasatinib on human oral cancer cells through multi-targeted mechanisms. | J Cell Mol Med | 2021 Sep |
2 |
| 913 | 34324169 | Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced Differentiation. | Target Oncol | 2021 Sep |
1 |
| 914 | 34336684 | STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1. | Front Oncol | 2021 |
4 |
| 915 | 34360855 | Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia. | Int J Mol Sci | 2021 Jul 28 |
2 |
| 916 | 34360911 | Pyrimethamine Modulates Interplay between Apoptosis and Autophagy in Chronic Myelogenous Leukemia Cells. | Int J Mol Sci | 2021 Jul 29 |
2 |
| 917 | 34367046 | Alprazolam Prompts HIV-1 Transcriptional Reactivation and Enhances CTL Response Through RUNX1 Inhibition and STAT5 Activation. | Front Neurol | 2021 |
1 |
| 918 | 34372612 | Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma. | Viruses | 2021 Jul 20 |
1 |
| 919 | 34396051 | AXL Inhibition Represents a Novel Therapeutic Approach in <i>BCR-ABL</i> Negative Myeloproliferative Neoplasms. | Hemasphere | 2021 Sep |
2 |
| 920 | 34408231 | Green nanotechnology of MGF-AuNPs for immunomodulatory intervention in prostate cancer therapy. | Sci Rep | 2021 Aug 18 |
1 |
| 921 | 34415853 | Improved green thermal activated delayed fluorescence OLEDs based on thermally evaporated distributed Bragg reflector (DBR) of MgF<sub>2</sub>/ZnS. | Nanotechnology | 2021 Aug 20 |
1 |
| 922 | 34443392 | Lignans from <i>Machilus thunbergii</i> as Thymic Stromal Lymphopoietin Inhibitors. | Molecules | 2021 Aug 8 |
2 |
| 923 | 34462525 | TET3 promotes AML growth and epigenetically regulates glucose metabolism and leukemic stem cell associated pathways. | Leukemia | 2022 Feb |
1 |
| 924 | 34506850 | Demonstration and implications of IL-3 upregulation of CD25 expression on human mast cells. | J Allergy Clin Immunol | 2022 Apr |
1 |
| 925 | 34536521 | Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease. | Brain Res Bull | 2021 Dec |
1 |
| 926 | 34545658 | MK-6, a novel not-α IL-2, elicits a potent antitumor activity by improving the effector to regulatory T cell balance. | Cancer Sci | 2021 Nov |
1 |
| 927 | 34630419 | Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis <i>In Vivo</i> and Baseline Signaling Profile Associates With Treatment Response. | Front Immunol | 2021 |
1 |
| 928 | 34635505 | GATM-Mediated Creatine Biosynthesis Enables Maintenance of FLT3-ITD-Mutant Acute Myeloid Leukemia. | Mol Cancer Res | 2022 Feb |
2 |
| 929 | 34638347 | Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis. | Cancers (Basel) | 2021 Sep 28 |
1 |
| 930 | 34650929 | Histone Deacetylase Inhibitor Trichostatin A Reduces Endothelial Cell Proliferation by Suppressing STAT5A-Related Gene Transcription. | Front Oncol | 2021 |
1 |
| 931 | 34665220 | Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity. | J Exp Med | 2021 Dec 6 |
1 |
| 932 | 34665271 | Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3. | Arch Toxicol | 2022 Jan |
1 |
| 933 | 34668282 | Tailoring Co3d and O2p Band Centers to Inhibit Oxygen Escape for Stable 4.6 V LiCoO<sub>2</sub> Cathodes. | Angew Chem Int Ed Engl | 2021 Dec 20 |
2 |
| 934 | 34673425 | JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia. | Biomed Pharmacother | 2021 Dec |
1 |
| 935 | 34715067 | Pharmacologic control of homeostatic and antigen-driven proliferation to target HIV-1 persistence. | Biochem Pharmacol | 2021 Dec |
1 |
| 936 | 34716187 | CSF2-STAT5 Signaling in TAMs Contributes to CSF1R Inhibition Resistance. | Cancer Discov | 2022 Jan |
2 |
| 937 | 34719574 | [Pharmacological characteristics and clinical study results of Pemigatinib (Pemazyre<sup>®</sup> Tablets), a selective fibroblast growth factor receptor (FGFR) inhibitor]. | Nihon Yakurigaku Zasshi | 2021 |
1 |
| 938 | 34745769 | Metformin promotes anticancer activity of NK cells in a p38 MAPK dependent manner. | Oncoimmunology | 2021 |
1 |
| 939 | 34749590 | Mutated JAK2 signal transduction in human Induced Pluripotent Stem Cell (iPSC)-derived Megakaryocytes. | Platelets | 2021 Nov 9 |
1 |
| 940 | 34761621 | FAT10 stimulates the development of osteosarcoma by regulating the JAK/STAT signaling pathway. | J BUON | 2021 Sep-Oct |
1 |
| 941 | 34827970 | Beta-Sitosterol Promotes Milk Protein and Fat Syntheses-Related Genes in Bovine Mammary Epithelial Cells. | Animals (Basel) | 2021 Nov 12 |
2 |
| 942 | 34842047 | STAT5 inhibitor Pimozide as a probable therapeutic option in overcoming Ponatinib resistance in K562 leukemic cells. | J Biomol Struct Dyn | 2021 Nov 28 |
7 |
| 943 | 34858500 | Key Markers Involved in the Anticolon Cancer Response of CD8+ T Cells through the Regulation of Cholesterol Metabolism. | J Oncol | 2021 |
1 |
| 944 | 34866251 | 22-kD growth hormone-induced nuclear GHR/STAT5/CyclinD1 signaling pathway plays an important role in promoting mesenchymal stem cell proliferation. | Biofactors | 2022 Jan |
2 |
| 945 | 34905258 | Asymmetrically Substituted m-Terphenyl Phosphates Inhibit the Transcription Factor STAT5a. | Chembiochem | 2022 Feb 16 |
6 |
| 946 | 34948112 | The Framework for Human Host Immune Responses to Four Types of Parasitic Infections and Relevant Key JAK/STAT Signaling. | Int J Mol Sci | 2021 Dec 10 |
2 |
| 947 | 34959180 | Degrading FLT3-ITD protein by proteolysis targeting chimera (PROTAC). | Bioorg Chem | 2022 Feb |
1 |
| 948 | 35136485 | GZ17-6.02 and axitinib interact to kill renal carcinoma cells. | Oncotarget | 2022 |
2 |
| 949 | 35167281 | Thermodynamic and Kinetic Studies on the Conversion of Solvent-Shared to Contact Ion Pairs in Sparingly Soluble MF<sub>2</sub> (M = Mg<sup>2+</sup> and Ca<sup>2+</sup>) Aqueous Solutions: Implications for Understanding Supersaturated Behavior and Association Constant Determination. | J Phys Chem B | 2022 Feb 24 |
2 |
| 950 | 35204716 | Exogenous Lactogenic Signaling Stimulates Beta Cell Replication In Vivo and In Vitro. | Biomolecules | 2022 Jan 26 |
1 |